• FirefoxUpgrade to the new Firefox »
  •  Dow Down1.13% Nasdaq Down0.93%

    Onconova Therapeutics, Inc. (ONTX)

    -NasdaqGS
    3.77 Up 0.15(4.14%) 4:00PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
    Total Revenue 114   125   447   1,930  
    Cost of Revenue -   -   -   -  
    Gross Profit 114   125   447   1,930  
    Operating Expenses
    Research Development11,886  12,904  14,248  12,086  
    Selling General and Administrative3,116  3,985  4,932  4,403  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (14,888) (16,764) (18,733) (14,559)
    Income from Continuing Operations
    Total Other Income/Expenses Net(19)(16)17  (62)
    Earnings Before Interest And Taxes(14,907)(16,780)(18,716)(14,621)
    Interest Expense -   -   -  4  
    Income Before Tax(14,907)(16,780)(18,716)(14,625)
    Income Tax Expense -   -   -  3  
    Minority Interest29  27  37  13  
    Net Income From Continuing Ops(14,878)(16,753)(18,679)(14,615)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (14,878) (16,753) (18,679) (14,615)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (14,878) (16,753) (18,679) (14,615)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.